TriSalus Life Sciences, Inc. TLSI Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 85.1%+0.5pp | 84.6%+0.5pp | 84%-0.6pp | 84.7%-0.9pp | 85.6%-0.5pp | |
| Operating margin | -62.4%-2.8pp | -59.7%+18.1pp | -77.7%+8.3pp | -86.1%+12.9pp | -99%+23.9pp | |
| Net margin | -60.9%+26.0pp | -86.9%+11.6pp | -98.4%-11.8pp | -86.6%-1.9pp | -84.7%+17.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×-0.6× | 1.5×+0.3× | 1.3×+0.3× | 1×-0.4× | 1.4×+0.2× | |
| Liquidity | ||||||
| Current ratio | 5.8×+3.0× | 2.8×-0.3× | 3.1×-1.0× | 4.1×+1.9× | 2.1×+0.1× | |
| Per Share | ||||||
| Book value per share | $0.24+127% | -$0.89-44.0% | -$0.62-5.1% | -$0.59+51.0% | -$1.20-17.9% | |
| Valuation | ||||||
| Market capitalization | $279.45M+49.6% | $348.75M+50.4% | $231.88M+16.8% | $198.61M+15.0% | $172.66M+13.0% | |
| Price / sales | 6.2×+1.0× | 7.7×+2.0× | 5.8×+0.2× | 5.5×+0.1× | 5.4×+0.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TriSalus Life Sciences, Inc.'s profit margins?
- TriSalus Life Sciences, Inc. (TLSI) runs a 85.1% gross margin and a -62.4% operating margin, with a -60.9% net margin.
- Where do TriSalus Life Sciences, Inc.'s ratios come from?
- Every ratio is computed from TriSalus Life Sciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
